The best indicator for Boston Scientific (BSX)
We backtested 20 indicators across daily, weekly and hourly charts on real Boston Scientific (BSX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Breakout
On the weekly chart, this is the strongest risk-adjusted edge we found for Boston Scientific (BSX) over ~34.2 years — trailing buy-and-hold by 1.0% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Breakout ✓ | Weekly | 6.2% | 0.43 | -48.4% | 53.6% | 28 | -1.0% |
| 2 | EMA 50/200 Cross ✓ | Daily | 7.4% | 0.41 | -77.9% | 38.9% | 18 | 0.0% |
| 3 | Donchian Midline ✓ | Weekly | 7.5% | 0.41 | -70.4% | 41.9% | 93 | 0.3% |
| 4 | EMA 20/50 Cross ✓ | Weekly | 9.4% | 0.49 | -67.2% | 33.3% | 12 | 2.2% |
| 5 | Donchian Breakout ✓ | Weekly | 6.1% | 0.38 | -74.2% | 48.1% | 27 | -1.1% |
| 6 | Rate of Change ✓ | Weekly | 6.1% | 0.37 | -76.8% | 40.8% | 103 | -1.0% |
| 7 | EMA-10 Trend ✓ | Weekly | 5.9% | 0.36 | -61.4% | 42.7% | 157 | -1.2% |
| 8 | ADX / DMI ✓ | Weekly | 4.6% | 0.34 | -53.7% | 50.0% | 50 | -2.6% |
| 9 | EMA 20/50 Cross ✓ | Daily | 5.4% | 0.33 | -82.3% | 37.2% | 78 | -2.0% |
| 10 | RSI Trend (>50) ✓ | Weekly | 5.1% | 0.33 | -72.3% | 43.8% | 89 | -2.0% |
| 11 | Bollinger Mean-Reversion ✓ | Daily | 4.3% | 0.3 | -58.8% | 69.9% | 146 | -3.1% |
| 12 | MACD ✓ | Weekly | 4.5% | 0.3 | -85.7% | 49.4% | 77 | -2.7% |
| 13 | SMA 50/200 Cross ✓ | Daily | 3.5% | 0.26 | -89.8% | 44.0% | 25 | -3.9% |
| 14 | ADX / DMI ✓ | Daily | 3.0% | 0.25 | -67.2% | 43.3% | 210 | -4.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Boston Scientific (BSX), Bollinger Breakout on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.